Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials

Abstract Background We report long-term, end-of-study program safety outcomes from 25 randomized clinical trials (RCTs) in adult patients with psoriasis (PsO), psoriatic arthritis (PsA), or axial spondyloarthritis (axSpA) [including ankylosing spondylitis (AS) and non-radiographic axial spondyloarth...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Atul Deodhar, Andrew Blauvelt, Mark Lebwohl, Meghan Feely, Andris Kronbergs, Nadezhda Eberhart, Danting Zhu, Elsa Inman, Elsie Grace, Thorsten Holzkaemper, Proton Rahman, Helena Marzo-Ortega, Kim A. Papp, Joseph F. Merola, Alice B. Gottlieb, Sergio Schwartzman
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2024-02-01
Saila:	Arthritis Research & Therapy
Gaiak:	Ixekizumab Psoriasis Psoriatic arthritis Axial Spondyloarthritis Long-term Safety Integrated Safety
Sarrera elektronikoa:	https://doi.org/10.1186/s13075-023-03257-7
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!